Q32 Bio Q4 2024 GAAP EPS $(1.16) Beats $(1.51) Estimate, Cash And Cash Equivalents Of $78M As Of December 31, 2024 Expected To Provide Financial Runway Into 2H 2026

Benzinga
11 Mar

Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(1.51) by 23.18 percent.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10